Empire Life Investments Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Empire Life Investments Inc.
- $1.52 Billion
- Q2 2025
A detailed history of Empire Life Investments Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Empire Life Investments Inc. holds 264,012 shares of ARCT stock, worth $3.93 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
264,012
Previous 264,909
0.34%
Holding current value
$3.93 Million
Previous $2.81 Million
22.42%
% of portfolio
0.23%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding ARCT
# of Institutions
170Shares Held
25.9MCall Options Held
321KPut Options Held
120K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$69.9 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$39.5 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$27.3 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$27.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$27 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $396M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...